The German Biobank Node (GBN), which is part of BBMRI-ERIC, asked more than 330 “potential biobank users” at university hospitals about their attitudes towards collaborating with biobanks. Here, Dr. Cornelia Specht, managing director of the GBN, tells us about the survey results and conclusions.
In our latest blog post we meet Sue Ring, Head of Laboratories and Executive Director of the Avon Longitudinal Study of Parents and Children (ALSPAC) at the University of Bristol, to find out more about her work.
King’s Health Partners Cancer Biobank at Guy’s and St Thomas’ and Focus Games have developed a digital biobanking game. Here, Dr. Cheryl Gillett, Head of Biobanking at King’s College London, tells us more.
In our latest blog post we meet Giuseppe Mazza, PhD., CEO and Co-Founder at Engitix Ltd to find out more about his work on developing acellular material from discarded human tissue (extracellular matrix) and applying this unique biomaterial for modelling human diseases such as fibrosis and cancer with the aim of developing better therapeutics.
In our latest blog post we meet Dr. Kirstin Goldring, Principal Scientist: Human Biological Sample Strategy and Governance at AstraZeneca, to find out more about her work.
In our latest blog post we meet Matt McLoughlin, VP Compliance and Categories at Scientist.com, to find out more about his work in supporting the pharmaceutical industry access regulated services to drive their R&D pipelines forward.